Skip to main content
PMC home page
The Journal of Experimental Medicine logoLink to The Journal of Experimental Medicine
. 1963 May 1;117(5):735–747. doi: 10.1084/jem.117.5.735

STUDIES ON THE MULTIPLICATION AND THE PROPERTIES OF THE LACTIC DEHYDROGENASE AGENT

Abner Louis Notkins 1, Stephen J Shochat 1
PMCID: PMC2137636  PMID: 13939042

Abstract

The procedure used to determine the infective titer of the LDH agent, the reproducibility of this assay, and the relationship between virus dose and plasma enzyme activity were described. Multiplication of the LDH agent began within 6 hours after infection and reached 1010.8 ID50/ml of plasma within 24 hours. The titer rapidly decreased over the next 72 hours but viremia persisted for at least 16 months with titers as high as 105.2 ID50/ml. The appearance of the LDH agent in the circulation preceded the first noticeable rise in plasma LDH activity by close to 24 hours. After 10 months, when the plasma titer of the LDH agent had decreased nearly one millionfold, the plasma enzyme LDH had decreased by less than 50 per cent. The LDH agent is inactivated by ether but withstands lyophilization, and freezing and thawing. It is stable at low temperatures. Ultracentrifugation at 105,000 G for 2 hours leaves less than 0.1 per cent of the LDH agent in the supernatant fluid and filtration through gradocol membranes suggesst that the upper size of the LDH agent is about 55 mµ. Spread of the LDH agent from infected to uninfected mice kept in the same cage and transmission from mothers (infected prior to mating) to their offspring was relatively low.

Full Text

The Full Text of this article is available as a PDF (638.5 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. ADAMS D. H., ROWSON K. E., SALAMAN M. H. The effect of tumours, of leukaemia, and of some viruses associated with them, on the plasma lactic dehydrogenase activity of mice. Br J Cancer. 1961 Dec;15:860–867. doi: 10.1038/bjc.1961.100. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. DULBECCO R., VOGT M. Plaque formation and isolation of pure lines with poliomyelitis viruses. J Exp Med. 1954 Feb;99(2):167–182. doi: 10.1084/jem.99.2.167. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. MOLONEY J. B. The murine leukemias. Fed Proc. 1962 Jan-Feb;21:19–31. [PubMed] [Google Scholar]
  4. NOTKINS A. L., GREENFIELD R. E. Infection of tumor-bearing mice with the lactic dehydrogenase agent. Proc Soc Exp Biol Med. 1962 Apr;109:988–991. doi: 10.3181/00379727-109-27400. [DOI] [PubMed] [Google Scholar]
  5. NOTKINS A. L., GREENFIELD R. E., MARSHALL D., BANE L. Multiple enzyme changes in the plasma of normal and tumor-bearing mice following infection with the lactic dehydrogenase agent. J Exp Med. 1963 Feb 1;117:185–195. doi: 10.1084/jem.117.2.185. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. RILEY V. Adaptation of orbital bleeding technic to rapid serial blood studies. Proc Soc Exp Biol Med. 1960 Aug-Sep;104:751–754. doi: 10.3181/00379727-104-25975. [DOI] [PubMed] [Google Scholar]
  7. RILEY V. Virus-tumor synergism. Science. 1961 Sep 8;134(3480):666–668. doi: 10.1126/science.134.3480.666-a. [DOI] [PubMed] [Google Scholar]
  8. Riley V., Lilly F., Huerto E., Bardell D. Transmissible Agent Associated with 26 Types of Experimental Mouse Neoplasms. Science. 1960 Aug 26;132(3426):545–547. doi: 10.1126/science.132.3426.545. [DOI] [PubMed] [Google Scholar]
  9. WROBLEWSKI F., LADUE J. S. Lactic dehydrogenase activity in blood. Proc Soc Exp Biol Med. 1955 Oct;90(1):210–213. doi: 10.3181/00379727-90-21985. [DOI] [PubMed] [Google Scholar]
  10. YAFFE D. The distribution and in vitro propagation of an agent causing high plasma lactic dehydrogenase activity. Cancer Res. 1962 Jun;22:573–580. [PubMed] [Google Scholar]

Articles from The Journal of Experimental Medicine are provided here courtesy of The Rockefeller University Press

RESOURCES